MUM bags Hockey WA deal

Published 11-APR-2016 11:28 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Mount Magnet South (ASX:MUM) RTO target Gameday Mouthguards has continued it push into grassroots sport, clinching a deal with Hockey WA.

MUM told the market today that Gameday has sealed a deal with Hockey WA to promote its product to Hockey WA’s 25,000 members.

As part of a two-year agreement, gameday will gain access to the members via social media, newsletters, and an on-ground presence at key events.

This includes WA Hockey’s grading carnival, which attracts about 3000 players.

News of the new deal comes shortly after Gameday signed a similar deal with Southern Football Netball League.

The push into the grassroots is an ongoing strategy for the company, hoping to build an initial market for its custom-fitted mouthguards.

The gameplan

Gameday is in the process of undertaking a reverse takeover of MUM, and is aiming to disrupt the mouthguard market by providing custom-made mouthguards at a low price point.

It estimates high-end custom mouthguards can cost up to $300, while over-the-counter options go for about $20 but provide little protection.

When health rebates are taken into account, MUM is hoping to sell custom-made mouthguards at low cost.

The Australian Dental Association claims only 36% of Australian children aged 15-17 wear mouthguards during games, this makes Gameday’s business model highly scalable.

Given the pedigree of Gameday’s executives, however, the company is also focused on educating sporting clubs about the necessity of wearing a mouthguard to prevent the potentiality of any facial injury occurring.

On the board are Essendon and AFL legend John Worsfold, while it recently snagged four-time Olympian David Neesham as a technical advisor, and NRL favourite Matt Ballin as a brand ambassador.

CEO Matt Weston has worked in the business and sporting industry for over 20 years throughout Asia and Australia and was a key executive in the NBA with the San Antonio Spurs and influencer with the Beijing Olympics.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X